Swiss National Bank Wave Life Sciences Ltd. Transaction History

Swiss National Bank

  • $150 Billion
  • Q3 2024

A detailed history of Swiss National Bank transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Swiss National Bank holds 156,500 shares of WVE stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
156,500
Previous 156,500 -0.0%
Holding current value
$1.76 Million
Previous $780,000 64.49%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
BUY
$3.54 - $6.84 $14,514 - $28,044
4,100 Added 2.69%
156,500 $965,000
Q4 2023

Feb 06, 2024
BUY
$4.16 - $6.87 $633,984 - $1.05 Million
152,400 New
152,400 $769,000
Q2 2021

Aug 06, 2021
SELL
$5.65 - $7.47 $409,625 - $541,575
-72,500 Closed
0 $0
Q1 2021

May 07, 2021
BUY
$5.61 - $12.01 $34,221 - $73,261
6,100 Added 9.19%
72,500 $407,000
Q3 2020

Nov 09, 2020
BUY
$8.49 - $19.54 $174,045 - $400,570
20,500 Added 44.66%
66,400 $564,000
Q2 2020

Aug 05, 2020
BUY
$7.44 - $11.29 $72,912 - $110,641
9,800 Added 27.15%
45,900 $478,000
Q4 2019

Feb 06, 2020
BUY
$7.99 - $37.6 $6,392 - $30,080
800 Added 2.27%
36,100 $289,000
Q3 2019

Nov 12, 2019
BUY
$19.17 - $27.4 $21,087 - $30,140
1,100 Added 3.22%
35,300 $725,000
Q2 2019

Aug 02, 2019
BUY
$22.93 - $42.84 $18,344 - $34,272
800 Added 2.4%
34,200 $892,000
Q1 2019

May 10, 2019
BUY
$32.69 - $47.91 $415,163 - $608,457
12,700 Added 61.35%
33,400 $1.3 Million
Q4 2018

Feb 13, 2019
BUY
$37.1 - $50.11 $48,230 - $65,143
1,300 Added 6.7%
20,700 $870,000
Q1 2018

May 04, 2018
BUY
$32.45 - $54.7 $32,450 - $54,700
1,000 Added 5.43%
19,400 $778,000
Q3 2017

Nov 03, 2017
BUY
$16.4 - $25.05 $301,760 - $460,920
18,400
18,400 $400,000

Others Institutions Holding WVE

# of Institutions
165
Shares Held
117M
Call Options Held
148K
Put Options Held
109K
View Full List

About Wave Life Sciences Ltd.

WVE Quotes by TradingView
  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $978M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email